News

Maas Biolab Subsidiary NeuroVive Pharmaceutical Raises $1.5 Million in Swedish Public Offering

October 3, 2008
New Mexico Economic Development Department: Maas BiolAB Awarded $2.1 Million SBIR

October 24, 2007
Maas BiolAB Awarded $2.1 Million SBIR for Cyclosporin ALS Treatment

October 11, 2007
Maas BiolAB Presents to Investor Forum

May 7, 2007
TEDCO Awards Four Companies a Total of $200,000 from Ft. Detrick Technology Transfer Initiative

May 2, 2007
Lundaforskning om skydd mot nervgasskador (Lund Research Protects Against Nerve Gas Damage)

(Lund University, Sweden) February 7, 2007
Maas BiolAB Awarded Department of Defense/DTRA Contract

(BUSINESS WIRE) February 5, 2007
Two New Compounds Target Cell Death by Mitochondria

(MDA/ALS Newsmagazine) v12 n2 February 2007


2006 News
2005 News

2004 News

2003 News
2002 News
2001 News
2000 News
1999 News

 

 

© Maas Biolab All rights reserved